title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Thursday,20220428T193101,https://www.benzinga.com/markets/options/22/04/26872967/52-weeks-high-and-low-article,MDXG,0.00644,Neutral,0.004656
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,MDXG,0.005366,Neutral,-0.006823
Stocks That Hit 52-Week Lows On Tuesday,20220426T174457,https://www.benzinga.com/markets/options/22/04/26818122/52-weeks-high-and-low-article,MDXG,0.00928,Neutral,0.006049
Stocks That Hit 52-Week Lows On Wednesday,20220427T184104,https://www.benzinga.com/markets/options/22/04/26844275/52-weeks-high-and-low-article,MDXG,0.006956,Neutral,-0.00859
"Earnings Scheduled For May 3, 2022",20220503T085235,https://www.benzinga.com/news/earnings/22/05/26953640/earnings-scheduled-for-may-3-2022,MDXG,0.01558,Neutral,-0.076647
"Poseida Therapeutics, Inc.  ( PSTX )  Hits Fresh High: Is There Still Room to Run?",20241213T141503,https://www.zacks.com/stock/news/2383276/poseida-therapeutics-inc-pstx-hits-fresh-high-is-there-still-room-to-run,MDXG,0.470894,Bullish,0.466677
MIMEDX to Participate in Upcoming Investor Conferences - MiMedx Group  ( NASDAQ:MDXG ) ,20241204T130000,https://www.benzinga.com/pressreleases/24/12/g42312770/mimedx-to-participate-in-upcoming-investor-conferences,MDXG,0.817578,Bullish,0.563488
"Poseida Therapeutics, Inc.  ( PSTX )  Hit a 52 Week High, Can the Run Continue?",20241127T141507,https://www.zacks.com/stock/news/2375920/poseida-therapeutics-inc-pstx-hit-a-52-week-high-can-the-run-continue,MDXG,0.475251,Bullish,0.469028
How Much Upside is Left in MiMedx  ( MDXG ) ? Wall Street Analysts Think 37.12%,20241120T145510,https://www.zacks.com/stock/news/2372802/how-much-upside-is-left-in-mimedx-mdxg-wall-street-analysts-think-3712,MDXG,0.285526,Somewhat-Bullish,0.29098
MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs,20241114T141500,https://www.globenewswire.com/news-release/2024/11/14/2981300/0/en/MIMEDX-s-Advocacy-to-Rein-in-Runaway-Medicare-Spend-for-Skin-Substitutes-Has-Yielded-Significant-Results-with-Planned-Implementation-of-LCDs.html,MDXG,0.454174,Somewhat-Bullish,0.252342
"ChromaDex Corporation  ( CDXC )  Hit a 52 Week High, Can the Run Continue?",20241105T141507,https://www.zacks.com/stock/news/2364265/chromadex-corporation-cdxc-hit-a-52-week-high-can-the-run-continue,MDXG,0.472338,Bullish,0.467459
Can MiMedx  ( MDXG )  Climb 77.92% to Reach the Level Wall Street Analysts Expect?,20241104T145508,https://www.zacks.com/stock/news/2363476/can-mimedx-mdxg-climb-7792-to-reach-the-level-wall-street-analysts-expect,MDXG,0.286193,Somewhat-Bullish,0.312911
MiMedx  ( MDXG )  Q3 Earnings and Revenues Surpass Estimates,20241030T212506,https://www.zacks.com/stock/news/2361048/mimedx-mdxg-q3-earnings-and-revenues-surpass-estimates,MDXG,0.401331,Neutral,0.143183
MIMEDX Announces Third Quarter 2024 Operating and Financial Results,20241030T200100,https://www.globenewswire.com/news-release/2024/10/30/2972036/0/en/MIMEDX-Announces-Third-Quarter-2024-Operating-and-Financial-Results.html,MDXG,0.133428,Neutral,0.135457
MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue - MiMedx Group  ( NASDAQ:MDXG ) ,20241008T200100,https://www.benzinga.com/pressreleases/24/10/g41238720/mimedx-points-to-the-new-york-times-article-on-the-vast-benefits-of-placental-tissue,MDXG,0.810034,Bullish,0.587471
MIMEDX Announces Launch of HELIOGENâ„¢ Fibrillar Collagen Matrix - MiMedx Group  ( NASDAQ:MDXG ) ,20240731T200200,https://www.benzinga.com/pressreleases/24/07/g40080497/mimedx-announces-launch-of-heliogen-fibrillar-collagen-matrix,MDXG,0.625937,Bullish,0.397886
MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature - Scientific Reports,20240722T121000,https://www.globenewswire.com/news-release/2024/07/22/2916510/0/en/MIMEDX-Announces-Publication-Focused-on-Surgical-Applications-Using-MIMEDX-Placental-Based-Allografts-in-Nature-Scientific-Reports.html,MDXG,0.512933,Bullish,0.478044
"Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives",20240717T120000,https://www.globenewswire.com/news-release/2024/07/17/2914481/8339/en/Cassava-Sciences-Announces-Changes-in-Executive-Leadership-Enhanced-Corporate-Governance-and-Other-Initiatives.html,MDXG,0.081276,Neutral,0.0
MiMedx Group  ( NASDAQ:MDXG )  Rating Increased to Strong-Buy at StockNews.com,20240711T052724,https://www.defenseworld.net/2024/07/11/mimedx-group-nasdaqmdxg-rating-increased-to-strong-buy-at-stocknews-com.html,MDXG,0.878204,Bullish,0.46358
"MiMedx Group  ( NASDAQ:MDXG )  Downgraded by StockNews.com to ""Buy""",20240704T082042,https://www.defenseworld.net/2024/07/04/mimedx-group-nasdaqmdxg-downgraded-by-stocknews-com-to-buy.html,MDXG,0.887891,Somewhat-Bullish,0.327389
MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer,20240626T200100,https://www.globenewswire.com/news-release/2024/06/26/2904805/0/en/MIMEDX-Announces-the-Appointment-of-Kim-Moller-to-Chief-Commercial-Officer.html,MDXG,0.872202,Bullish,0.469322
MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer - MiMedx Group  ( NASDAQ:MDXG ) ,20240626T200100,https://www.benzinga.com/pressreleases/24/06/g39511716/mimedx-announces-the-appointment-of-kim-moller-to-chief-commercial-officer,MDXG,0.859307,Bullish,0.460635
"Entrepreneur, Public Company CEO, and Philanthropist Parker H. ""Pete"" Petit Releases New Book ""The Entrepreneur's ... - PR Newswire",20240626T161700,https://www.prnewswire.com/news-releases/entrepreneur-public-company-ceo-and-philanthropist-parker-h-pete-petit-releases-new-book-the-entrepreneurs-dilemma-should-i-take-my-company-public-302183431.html,MDXG,0.304114,Somewhat-Bullish,0.346466
"Entrepreneur, Public Company CEO, and Philanthropist Parker H. ""Pete"" Petit Releases New Book ""The Entrepreneur's Dilemma: Should I Take My Company Public?""",20240626T161700,https://www.benzinga.com/pressreleases/24/06/n39507517/entrepreneur-public-company-ceo-and-philanthropist-parker-h-pete-petit-releases-new-book-the-entre,MDXG,0.284696,Somewhat-Bullish,0.33027
"MiMedx Group  ( NASDAQ:MDXG )  Upgraded by StockNews.com to ""Strong-Buy""",20240604T073257,https://www.defenseworld.net/2024/06/04/mimedx-group-nasdaqmdxg-upgraded-by-stocknews-com-to-strong-buy.html,MDXG,0.772194,Bullish,0.43396
"Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors - Spectral AI  ( NASDAQ:MDAIW ) , Spectral AI  ( NASDAQ:MDAI ) ",20240515T220521,https://www.benzinga.com/pressreleases/24/05/g38860891/spectral-ai-announces-voting-results-from-2024-annual-meeting-of-stockholders-and-the-appointment-,MDXG,0.097062,Neutral,-0.012793
Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors,20240515T220500,https://www.globenewswire.com/news-release/2024/05/15/2883007/0/en/Spectral-AI-Announces-Voting-Results-from-2024-Annual-Meeting-of-Stockholders-and-the-Appointment-of-Erich-Spangenberg-to-the-Board-of-Directors.html,MDXG,0.108466,Neutral,0.018731
MIMEDX to Participate in Upcoming Investor Conferences,20240515T120000,https://www.globenewswire.com/news-release/2024/05/15/2882353/0/en/MIMEDX-to-Participate-in-Upcoming-Investor-Conferences.html,MDXG,0.94553,Bullish,0.605023
MIMEDX to Participate in Upcoming Investor Conferences - MiMedx Group  ( NASDAQ:MDXG ) ,20240515T120000,https://www.benzinga.com/pressreleases/24/05/g38841018/mimedx-to-participate-in-upcoming-investor-conferences,MDXG,0.84035,Bullish,0.567785
StockNews.com Downgrades MiMedx Group  ( NASDAQ:MDXG )  to Buy,20240507T071046,https://www.defenseworld.net/2024/05/07/stocknews-com-downgrades-mimedx-group-nasdaqmdxg-to-buy.html,MDXG,0.694939,Bullish,0.401951
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30,20240416T120000,https://www.globenewswire.com/news-release/2024/04/16/2863527/0/en/MIMEDX-to-Host-First-Quarter-2024-Operating-and-Financial-Results-Conference-Call-on-April-30.html,MDXG,0.919462,Bullish,0.482334
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX - TELA Bio  ( NASDAQ:TELA ) ,20240320T110000,https://www.benzinga.com/pressreleases/24/03/g37842041/tela-bio-announces-sale-of-distribution-rights-for-wound-care-product-to-mimedx,MDXG,0.325637,Somewhat-Bullish,0.242395
"Spectral AI Appoints Peter M. Carlson as CEO - Spectral AI  ( NASDAQ:MDAIW ) , Spectral AI  ( NASDAQ:MDAI ) ",20240229T223052,https://www.benzinga.com/pressreleases/24/02/g37409553/spectral-ai-appoints-peter-m-carlson-as-ceo,MDXG,0.079217,Somewhat-Bullish,0.190769
Spectral AI Appoints Peter M. Carlson as CEO,20240229T223000,https://www.globenewswire.com/news-release/2024/02/29/2838486/0/en/Spectral-AI-Appoints-Peter-M-Carlson-as-CEO.html,MDXG,0.082017,Somewhat-Bullish,0.191844
MIMEDX to Present at TD Cowen 44th Annual Health Care Conference,20240220T130000,https://www.globenewswire.com/news-release/2024/02/20/2831750/0/en/MIMEDX-to-Present-at-TD-Cowen-44th-Annual-Health-Care-Conference.html,MDXG,0.839046,Bullish,0.64272
MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28,20240212T130000,https://www.globenewswire.com/news-release/2024/02/12/2827465/0/en/MIMEDX-to-Host-Fourth-Quarter-and-Full-Year-2023-Operating-and-Financial-Results-Conference-Call-on-February-28.html,MDXG,0.913524,Bullish,0.474701
"Amniotic Membrane Market is Projected to Surpass USD 5.2 billion by 2031, Growing at CAGR 9.9%- Report by Transparency Market Research, Inc.",20240208T114500,https://www.benzinga.com/pressreleases/24/02/g37003540/amniotic-membrane-market-is-projected-to-surpass-usd-5-2-billion-by-2031-growing-at-cagr-9-9-repor,MDXG,0.033609,Neutral,0.063438
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG - MiMedx Group  ( NASDAQ:MDXG ) ",20240126T172214,https://www.benzinga.com/pressreleases/24/01/g36805727/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-mimedx-group-in,MDXG,0.608634,Neutral,0.025041
"ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages MiMedx Group, Inc. Investors to Inquire About Securities Class Action Investigation - MDXG - MiMedx Group  ( NASDAQ:MDXG ) ",20240126T004400,https://www.benzinga.com/pressreleases/24/01/g36794414/rosen-a-globally-respected-law-firm-encourages-mimedx-group-inc-investors-to-inquire-about-securit,MDXG,0.368227,Neutral,0.010334
MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing - MiMedx Group  ( NASDAQ:MDXG ) ,20240122T130000,https://www.benzinga.com/pressreleases/24/01/g36714267/mimedx-announces-improved-capital-structure-with-new-senior-secured-credit-facilities-and-debt-ref,MDXG,0.409318,Bullish,0.466088
Tissue Engineering Market is Expected to Reach $8.9 Billion | MarketsandMarketsâ„¢,20240122T123000,https://www.benzinga.com/pressreleases/24/01/g36713761/tissue-engineering-market-is-expected-to-reach-8-9-billion-marketsandmarkets,MDXG,0.03792,Neutral,-0.040123
"MDXG LOSS ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Encourages MiMedx Group, Inc. Investors to Inquire About Securities Class Action Investigation - MDXG - MiMedx Group  ( NASDAQ:MDXG ) ",20240120T150400,https://www.benzinga.com/pressreleases/24/01/g36707060/mdxg-loss-alert-rosen-national-trial-counsel-encourages-mimedx-group-inc-investors-to-inquire-abou,MDXG,0.368227,Neutral,0.012915
GSK: 3 A-Rated Medical Stocks to Watch and Buy,20240117T193121,https://stocknews.com/news/gsk-nhc-mdxg-3-a-rated-medical-stocks-to-watch-and-buy/,MDXG,0.118793,Neutral,0.102212
"MIMEDX ALERT: Bragar Eagel & Squire, P.C. is Investigating MiMedx Group, Inc. on Behalf of MiMedx Stockholders and Encourages Investors to Contact the Firm - MiMedx Group  ( NASDAQ:MDXG ) ",20240116T043000,https://www.benzinga.com/pressreleases/24/01/g36634314/mimedx-alert-bragar-eagel-squire-p-c-is-investigating-mimedx-group-inc-on-behalf-of-mimedx-stockho,MDXG,0.713878,Neutral,0.046563
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG",20240114T164500,https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-mimedx-group-inc---mdxg-302033849.html,MDXG,0.646507,Neutral,0.081092
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG",20240106T163000,https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-mimedx-group-inc---mdxg-302027542.html,MDXG,0.646507,Neutral,0.081092
"SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG - MiMedx Group  ( NASDAQ:MDXG ) ",20240102T221127,https://www.benzinga.com/pressreleases/24/01/g36461445/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-mimedx-group-in,MDXG,0.608634,Neutral,0.025041
"Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday - Amprius Technologies  ( NYSE:AMPX ) , ARM Holdings  ( NASDAQ:ARM ) ",20240102T164708,https://www.benzinga.com/news/24/01/36455106/rivian-automotive-reports-weak-delivery-figures-joins-joyy-mimedx-group-and-other-big-stocks-moving,MDXG,0.16849,Neutral,0.005653
MIMEDX Provides AXIOFILLÂ® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook,20231229T220000,https://www.globenewswire.com/news-release/2023/12/29/2802179/0/en/MIMEDX-Provides-AXIOFILL-Update-Reiterates-2023-Full-Year-Net-Sales-and-Fourth-Quarter-Adjusted-EBITDA-Margin-Outlook.html,MDXG,0.481586,Somewhat-Bullish,0.311727
MIMEDX Provides AXIOFILLÂ® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook - MiMedx Group  ( NASDAQ:MDXG ) ,20231229T220000,https://www.benzinga.com/pressreleases/23/12/g36435395/mimedx-provides-axiofill-update-reiterates-2023-full-year-net-sales-and-fourth-quarter-adjusted-eb,MDXG,0.464174,Somewhat-Bullish,0.299334
MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock,20231228T130000,https://www.globenewswire.com/news-release/2023/12/28/2801671/0/en/MIMEDX-Announces-Conversion-of-Outstanding-Series-B-Convertible-Preferred-Stock-to-Common-Stock.html,MDXG,0.703273,Bullish,0.507448
CAH: 3 Medical Stocks Diagnosing Weekly Profit Potential,20231121T125636,https://stocknews.com/news/cah-mdxg-natr-3-medical-stocks-diagnosing-weekly-profit-potential/,MDXG,0.1372,Neutral,0.121824
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update,20231121T120200,https://www.globenewswire.com/news-release/2023/11/21/2783933/30505/en/MediWound-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Company-Update.html,MDXG,0.017638,Neutral,0.002662
CAH: 3 Medical Stocks Elevating Investors' Profit Potential,20231120T160756,https://stocknews.com/news/cah-fsnuy-mdxg-3-medical-stocks-elevating-investors-profit-potential/,MDXG,0.14573,Somewhat-Bullish,0.161426
HSIC: Henry Schein  ( HSIC )  Q3 Earnings Analysis: A Medical Stock to Watch?,20231117T123331,https://stocknews.com/news/hsic-ocpny-mdxg-fonr-henry-schein-hsic-q3-earnings-analysis-a-medical-stock-to/,MDXG,0.066598,Neutral,0.007054
"ALC: Assessing Alcon Inc.'s  ( ALC )  Post-Earnings Prospects: Is It Time to Invest, Hold, or Let Go?",20231116T172722,https://stocknews.com/news/alc-fonr-mdxg-vrex-assessing-alcon-inc-s-alc-post-earnings-prospects-is-it-time-to/,MDXG,0.050306,Neutral,0.123272
MIMEDX to Participate in Upcoming Investor Conferences - MiMedx Group  ( NASDAQ:MDXG ) ,20231113T130000,https://www.benzinga.com/pressreleases/23/11/g35746507/mimedx-to-participate-in-upcoming-investor-conferences,MDXG,0.595343,Bullish,0.509349
BDX: Becton Dickinson & Co.  ( BDX )  Earnings Moves: A Buy or Sell for Investors?,20231108T180757,https://stocknews.com/news/bdx-fonr-mdxg-elmd-becton-dickinson-co-bdx-earnings-moves-a-buy-or/,MDXG,0.049629,Somewhat-Bullish,0.155133
MIMEDX to Highlight Published Data at SAWC Fall - MiMedx Group  ( NASDAQ:MDXG ) ,20231102T120000,https://www.benzinga.com/pressreleases/23/11/g35560679/mimedx-to-highlight-published-data-at-sawc-fall,MDXG,0.301686,Somewhat-Bullish,0.349307
"Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday - AppFolio  ( NASDAQ:APPF ) , Amazon.com  ( NASDAQ:AMZN ) ",20231027T155700,https://www.benzinga.com/news/23/10/35465271/chipotle-amazon-deckers-outdoor-capital-one-and-other-stocks-move-higher-on-friday,MDXG,0.175221,Neutral,0.0
An Update on My Top Small-Cap Pick and What It Means for the Overall Market,20230926T153000,https://realmoney.thestreet.com/investing/updating-my-top-small-cap-pick-and-what-it-means-for-the-overall-market-16134122,MDXG,0.191929,Neutral,0.079863
MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update,20230815T200300,https://www.globenewswire.com/news-release/2023/08/15/2725894/30505/en/MediWound-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Company-Update.html,MDXG,0.018482,Neutral,0.059898
Wound Healing Technology Company Merakris Adds Two Executives to Leadership Team,20230815T103000,https://www.benzinga.com/pressreleases/23/08/g33853704/wound-healing-technology-company-merakris-adds-two-executives-to-leadership-team,MDXG,0.037329,Neutral,0.103929
StockNews.com Upgrades MiMedx Group  ( NASDAQ:MDXG )  to Strong-Buy,20230803T063041,https://www.defenseworld.net/2023/08/03/stocknews-com-upgrades-mimedx-group-nasdaqmdxg-to-strong-buy.html,MDXG,0.765213,Bullish,0.397155
MiMedx Group  ( NASDAQ:MDXG )  Downgraded to Buy at StockNews.com,20230723T051645,https://www.defenseworld.net/2023/07/23/mimedx-group-nasdaqmdxg-downgraded-to-buy-at-stocknews-com.html,MDXG,0.862291,Bullish,0.540001
TRUMY: Are These 3 Medical Stocks a Safe Investment?,20230720T182338,https://stocknews.com/news/trumy-hae-mdxg-are-these-3-medical-stocks-a-safe-investment/,MDXG,0.181331,Somewhat-Bullish,0.212898
MiMedx Group  ( NASDAQ:MDXG )  Upgraded by StockNews.com to Strong-Buy,20230715T051444,https://www.defenseworld.net/2023/07/15/mimedx-group-nasdaqmdxg-upgraded-by-stocknews-com-to-strong-buy.html,MDXG,0.683843,Bullish,0.489156
"Active Wound Care Market Size is projected to reach USD 1.68 billion by 2030, growing at a CAGR of 4.6%: Straits Research",20230710T152000,https://www.benzinga.com/pressreleases/23/07/g33168827/active-wound-care-market-size-is-projected-to-reach-usd-1-68-billion-by-2030-growing-at-a-cagr-of-,MDXG,0.039548,Somewhat-Bearish,-0.195
"MiMedx Group  ( NASDAQ:MDXG )  Lowered to ""Buy"" at StockNews.com",20230708T074249,https://www.defenseworld.net/2023/07/08/mimedx-group-nasdaqmdxg-lowered-to-buy-at-stocknews-com.html,MDXG,0.73758,Bullish,0.424963
MIMEDX Appoints Doug Rice as Chief Financial Officer,20230705T120000,https://www.globenewswire.com/news-release/2023/07/05/2699452/0/en/MIMEDX-Appoints-Doug-Rice-as-Chief-Financial-Officer.html,MDXG,0.407844,Somewhat-Bullish,0.307109
MIMEDX Appoints Doug Rice as Chief Financial Officer - MiMedx Group  ( NASDAQ:MDXG ) ,20230705T120000,https://www.benzinga.com/pressreleases/23/07/g33113766/mimedx-appoints-doug-rice-as-chief-financial-officer,MDXG,0.40348,Somewhat-Bullish,0.302373
"MiMedx Targets Profitability with Strategic Realignment, Suspends Knee Osteoarthritis Program Activities - MiMedx Group  ( NASDAQ:MDXG ) ",20230621T125404,https://www.benzinga.com/news/23/06/32941702/mimedx-targets-profitability-with-strategic-realignment-suspends-knee-osteoarthritis-program-activit,MDXG,0.622414,Bullish,0.585274
"MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability - MiMedx Group  ( NASDAQ:MDXG ) ",20230620T200100,https://www.benzinga.com/pressreleases/23/06/g32934216/mimedx-announces-strategic-realignment-increases-focus-on-wound-surgical-business-expected-to-sign,MDXG,0.308891,Somewhat-Bullish,0.288283
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors - Alkermes  ( NASDAQ:ALKS ) ,20230613T110000,https://www.benzinga.com/pressreleases/23/06/n32831446/alkermes-issues-letter-to-shareholders-highlighting-skills-and-experience-of-refreshed-board-of-di,MDXG,0.009551,Neutral,0.0
MiMedx Group  ( NASDAQ:MDXG )  Upgraded to Strong-Buy by StockNews.com,20230603T095245,https://www.defenseworld.net/2023/06/03/mimedx-group-nasdaqmdxg-upgraded-to-strong-buy-by-stocknews-com.html,MDXG,0.70166,Somewhat-Bullish,0.308821
Here's Why You Should Retain Integra  ( IART )  Stock Now,20230530T120700,https://www.zacks.com/stock/news/2101232/heres-why-you-should-retain-integra-iart-stock-now,MDXG,0.044885,Neutral,0.047625
MiMedx Group  ( NASDAQ:MDXG )  Lowered to Buy at StockNews.com,20230526T092901,https://www.defenseworld.net/2023/05/26/mimedx-group-nasdaqmdxg-lowered-to-buy-at-stocknews-com.html,MDXG,0.716023,Bullish,0.44452
MiMedx Group President Trades Company's Stock - MiMedx Group  ( NASDAQ:MDXG ) ,20230518T150313,https://www.benzinga.com/news/23/05/32468855/mimedx-group-president-trades-companys-stock,MDXG,0.514619,Somewhat-Bullish,0.287604
"Skin Graft Market  ( Product, Graft Thickness )  - Reach $1.67Bn by 2028 at 7% CAGR with Autologous Segment Driving Growth During 2021-2028 | The Insight Partners",20230518T145449,https://www.benzinga.com/pressreleases/23/05/g32468554/skin-graft-market-product-graft-thickness-reach-1-67bn-by-2028-at-7-cagr-with-autologous-segment-d,MDXG,0.036587,Neutral,0.021427
MiMedx Group  ( NASDAQ:MDXG )  Cut to Buy at StockNews.com,20230512T052042,https://www.defenseworld.net/2023/05/12/mimedx-group-nasdaqmdxg-cut-to-buy-at-stocknews-com.html,MDXG,0.792937,Bullish,0.424891
StockNews.com Upgrades MiMedx Group  ( NASDAQ:MDXG )  to Strong-Buy,20230506T082648,https://www.defenseworld.net/2023/05/06/stocknews-com-upgrades-mimedx-group-nasdaqmdxg-to-strong-buy.html,MDXG,0.759979,Bullish,0.425235
MiMedx Group  ( NASDAQ:MDXG )  Cut to Buy at StockNews.com,20230420T052643,https://www.defenseworld.net/2023/04/20/mimedx-group-nasdaqmdxg-cut-to-buy-at-stocknews-com.html,MDXG,0.790941,Bullish,0.466798
"MiMedx Group  ( NASDAQ:MDXG )  Upgraded to ""Strong-Buy"" at StockNews.com",20230413T084246,https://www.defenseworld.net/2023/04/13/mimedx-group-nasdaqmdxg-upgraded-to-strong-buy-at-stocknews-com.html,MDXG,0.745397,Somewhat-Bullish,0.333659
Advanced Wound Care Market is Expected to Reach $17.7 billion | MarketsandMarkets.,20230407T133000,https://www.benzinga.com/pressreleases/23/04/g31712115/advanced-wound-care-market-is-expected-to-reach-17-7-billion-marketsandmarkets,MDXG,0.03463,Neutral,0.021761
Regenerative Medicine Market is projected to grow at a CAGR of 18.40% by 2033: Visiongain Reports Ltd,20230405T110013,https://www.benzinga.com/pressreleases/23/04/g31675058/regenerative-medicine-market-is-projected-to-grow-at-a-cagr-of-18-40-by-2033-visiongain-reports-lt,MDXG,0.028798,Neutral,0.0
"StockNews.com has upgraded MiMedx Group  ( NASDAQ:MDXG )  to ""Strong-Buy.""",20230323T065522,https://beststocks.com/stocknews-com-has-upgraded-mimedx-group-nasdaqmd-2/,MDXG,0.731122,Somewhat-Bullish,0.303208
MIMEDX Comments on Recent Data Brief Published by Office of Inspector General,20230316T120000,https://www.globenewswire.com/news-release/2023/03/16/2628590/0/en/MIMEDX-Comments-on-Recent-Data-Brief-Published-by-Office-of-Inspector-General.html,MDXG,0.653008,Bullish,0.437119
StockNews.com has upgraded MiMedx Group  ( NASDAQ:MDXG )  to Strong-Buy.,20230314T235932,https://beststocks.com/stocknews-com-has-upgraded-mimedx-group-nasdaqmd/,MDXG,0.648283,Somewhat-Bullish,0.309148
MiMedx Group  ( NASDAQ:MDXG )  Upgraded to Strong-Buy at StockNews.com,20230314T052241,https://www.defenseworld.net/2023/03/14/mimedx-group-nasdaqmdxg-upgraded-to-strong-buy-at-stocknews-com.html,MDXG,0.671304,Bullish,0.383796
Regenerative Medicine Market is projected to grow at a CAGR of 18.40% by 2033: Visiongain Reports Ltd,20230313T110000,https://www.benzinga.com/pressreleases/23/03/g31315741/regenerative-medicine-market-is-projected-to-grow-at-a-cagr-of-18-40-by-2033-visiongain-reports-lt,MDXG,0.028798,Neutral,0.0
"StockNews.com Upgrades MiMedx Group  ( NASDAQ:MDXG )  to ""Strong-Buy""",20230305T063450,https://www.defenseworld.net/2023/03/05/stocknews-com-upgrades-mimedx-group-nasdaqmdxg-to-strong-buy.html,MDXG,0.769861,Bullish,0.44673
"Veritone, Samsara, Lexicon Pharmaceuticals And Other Big Stocks Moving Higher On Friday - C3.ai  ( NYSE:AI ) , Ardelyx  ( NASDAQ:ARDX ) ",20230303T164036,https://www.benzinga.com/news/23/03/31195577/veritone-samsara-lexicon-pharmaceuticals-and-other-big-stocks-moving-higher-on-friday,MDXG,0.195025,Bullish,0.499968
Amniotic Membrane Market Size Report  ( $2.80 Billion by 2028 )  Lead by Cryopreserved Amniotic Membrane Segment - Exclusive Report by The Insight Partners,20230221T130822,https://www.benzinga.com/pressreleases/23/02/g30984738/amniotic-membrane-market-size-report-2-80-billion-by-2028-lead-by-cryopreserved-amniotic-membrane-,MDXG,0.030958,Neutral,0.142757
Regenerative Medicine Market Growth Report  ( $37.48 Billion )  Lead by Increasing Adoption of Gene Therapies | The Insight Partners,20230209T140800,https://www.benzinga.com/pressreleases/23/02/g30833795/regenerative-medicine-market-growth-report-37-48-billion-lead-by-increasing-adoption-of-gene-thera,MDXG,0.030408,Neutral,0.100066
MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director,20230130T130000,https://www.benzinga.com/pressreleases/23/01/g30620476/mimedx-appoints-joseph-h-capper-as-chief-executive-officer-and-director,MDXG,0.423564,Bullish,0.441723
"MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates",20230109T130200,https://www.globenewswire.com/news-release/2023/01/09/2585209/0/en/MIMEDX-Confirms-Fourth-Quarter-and-Full-Year-2022-Net-Sales-Expectations-Comments-on-Evolving-Medicare-Reimbursement-Landscape-and-Provides-Corporate-Updates.html,MDXG,0.309864,Neutral,0.068023
MIMEDX Announces Commercial Launch of EPIFIXÂ® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED - MiMedx Group  ( NASDAQ:MDXG ) ,20230104T210100,https://www.benzinga.com/pressreleases/23/01/g30282316/mimedx-announces-commercial-launch-of-epifix-in-japan-with-exclusive-distribution-agreement-with-g,MDXG,0.388377,Somewhat-Bullish,0.263925
"BioStem Aims To Stay Ahead Of Competition Through Its Unique Processes And Versatile Offerings In Wound Healing - MiMedx Group  ( NASDAQ:MDXG ) , Organogenesis Hldgs  ( NASDAQ:ORGO ) ",20221208T131227,https://www.benzinga.com/general/biotech/22/12/30005552/biostem-aims-to-stay-ahead-of-competition-through-its-unique-processes-and-versatile-offerings-in,MDXG,0.188193,Neutral,-0.084945
"Wound Care Biologics Market Size is projected to reach USD 4.10 Billion by 2031, growing at a CAGR of 9.74%: Straits Research",20221122T153500,https://www.benzinga.com/pressreleases/22/11/g29825179/wound-care-biologics-market-size-is-projected-to-reach-usd-4-10-billion-by-2031-growing-at-a-cagr-,MDXG,0.030064,Somewhat-Bullish,0.172387
Global Amniotic Membrane Market is Predicted to Grow at a CAGR of ~5% During 2022-2031; Rise in Number of Burn Cases to Elevate Growth - Kenneth Research,20221020T075412,https://www.benzinga.com/pressreleases/22/10/g29336235/global-amniotic-membrane-market-is-predicted-to-grow-at-a-cagr-of-5-during-2022-2031-rise-in-numbe,MDXG,0.050948,Neutral,0.080458
"MiMedx Group  ( NASDAQ:MDXG )  Raised to ""Buy"" at StockNews.com",20221020T071053,https://www.etfdailynews.com/2022/10/20/mimedx-group-nasdaqmdxg-raised-to-buy-at-stocknews-com/,MDXG,0.799321,Bullish,0.556018
"Global Wound Care Market is Predicted to Grow at a CAGR of 4.7% During 2022-2031; Growing Population of Geriatrics, Rising Incidence of Burn Injuries, and Technological and Research Development is to Elevate the Market Growth- Research Nest",20221017T111054,https://www.benzinga.com/pressreleases/22/10/g29284852/global-wound-care-market-is-predicted-to-grow-at-a-cagr-of-4-7-during-2022-2031-growing-population,MDXG,0.024673,Neutral,0.094812
MIMEDX Announces Launch of AMNIOEFFECTâ„¢,20220919T110000,https://www.globenewswire.com/news-release/2022/09/19/2518149/0/en/MIMEDX-Announces-Launch-of-AMNIOEFFECT.html,MDXG,0.427597,Somewhat-Bullish,0.252295
"Bed Bath & Beyond  ( NASDAQ:BBBY ) , Catalyst Pharmaceuticals  ( NASDAQ:CPRX )  - Nikola, Bed Bath & Beyond And Some Other Big Stocks Moving Higher In Today's Pre-Market Session",20220914T112255,https://www.benzinga.com/news/22/09/28862364/nikola-bed-bath-beyond-and-some-other-big-stocks-moving-higher-in-todays-pre-market-session,MDXG,0.407844,Bullish,0.601792
MIMEDX EPIFIXÂ® Receives Reimbursement Approval in Japan,20220912T203000,https://www.globenewswire.com/news-release/2022/09/12/2514502/0/en/MIMEDX-EPIFIX-Receives-Reimbursement-Approval-in-Japan.html,MDXG,0.300088,Somewhat-Bullish,0.2593
MiMedx Group  ( NASDAQ:MDXG )  Stock Rating Lowered by StockNews.com,20220909T061648,https://www.etfdailynews.com/2022/09/09/mimedx-group-nasdaqmdxg-stock-rating-lowered-by-stocknews-com/,MDXG,0.862063,Bullish,0.432613
"MiMedx Group  ( NASDAQ:MDXG )  Lifted to ""Buy"" at StockNews.com",20220902T083647,https://www.etfdailynews.com/2022/09/02/mimedx-group-nasdaqmdxg-lifted-to-buy-at-stocknews-com/,MDXG,0.693563,Bullish,0.362007
"MiMedx Group  ( NASDAQ:MDXG )  Upgraded to ""Buy"" by StockNews.com",20220902T083641,https://reporter.am/2022/09/02/mimedx-group-nasdaqmdxg-upgraded-to-buy-by-stocknews-com.html,MDXG,0.618922,Somewhat-Bullish,0.270994
Why Index Funds Could Fade,20220812T124000,https://www.barrons.com/articles/stock-index-funds-bear-market-51660249958,MDXG,0.04531,Neutral,0.103942
Why Index Funds Could Fade,20220812T070000,https://www.barrons.com/articles/the-bear-market-could-finally-break-index-funds-51660287600,MDXG,0.04531,Neutral,0.103942
MiMedx Group  ( NASDAQ:MDXG )  Cut to Hold at StockNews.com,20220811T090842,https://reporter.am/2022/08/11/mimedx-group-nasdaqmdxg-cut-to-hold-at-stocknews-com.html,MDXG,0.655281,Somewhat-Bullish,0.198156
"MiMedx Group  ( NASDAQ:MDXG )  Lowered to ""Hold"" at StockNews.com",20220809T100244,https://www.defenseworld.net/2022/08/09/mimedx-group-nasdaqmdxg-lowered-to-hold-at-stocknews-com.html,MDXG,0.742397,Bullish,0.430878
MIMEDX Welcomes Kate Surdez as Chief Human Resources Officer,20220718T133523,https://www.benzinga.com/pressreleases/22/07/g28100211/mimedx-welcomes-kate-surdez-as-chief-human-resources-officer,MDXG,0.545493,Bullish,0.467575
MIMEDX Welcomes Kate Surdez as Chief Human Resources Officer,20220718T133500,https://www.globenewswire.com/news-release/2022/07/18/2481141/0/en/MIMEDX-Welcomes-Kate-Surdez-as-Chief-Human-Resources-Officer.html,MDXG,0.564813,Bullish,0.48352
Acro Biomedical Co Ltd and Adept Medical Ltd Among Leading Companies in the Tissue Engineered Skin Substitutes Pipeline Market | Globaldata Plc,20220706T113000,https://www.globenewswire.com/news-release/2022/07/06/2474819/0/en/Acro-Biomedical-Co-Ltd-and-Adept-Medical-Ltd-Among-Leading-Companies-in-the-Tissue-Engineered-Skin-Substitutes-Pipeline-Market-Globaldata-Plc.html,MDXG,0.142718,Neutral,0.006004
MIMEDX Engages Nordic Bioscience Clinical Development A/S to Propel Registrational Trials of Placental Biologic Injectable for Knee Osteoarthritis,20220615T123000,https://www.globenewswire.com/news-release/2022/06/15/2463099/0/en/MIMEDX-Engages-Nordic-Bioscience-Clinical-Development-A-S-to-Propel-Registrational-Trials-of-Placental-Biologic-Injectable-for-Knee-Osteoarthritis.html,MDXG,0.196866,Neutral,0.144588
Prescience Point Capital Management Says MiMedx Shareholders Have Spoken: Voiced Their Desire For Change,20220614T211600,https://www.benzinga.com/pressreleases/22/06/n27711160/prescience-point-capital-management-says-mimedx-shareholders-have-spoken-voiced-their-desire-for-c,MDXG,0.331802,Neutral,-0.072702
MIMEDX Reminds Shareholders to Pre-Register for the Upcoming Virtual 2022 Annual Meeting of Shareholders,20220603T120000,https://www.globenewswire.com/news-release/2022/06/03/2455969/0/en/MIMEDX-Reminds-Shareholders-to-Pre-Register-for-the-Upcoming-Virtual-2022-Annual-Meeting-of-Shareholders.html,MDXG,0.272636,Neutral,0.101167
MIMEDX Addresses Presentation by Prescience Point,20220602T120300,https://www.globenewswire.com/news-release/2022/06/02/2455182/0/en/MIMEDX-Addresses-Presentation-by-Prescience-Point.html,MDXG,0.290988,Neutral,0.066031
MIMEDX Receives $4.6 Million Award from the Department of Defense to Advance the Treatment of Combat Casualty Wounds and Burns,20220531T120000,https://www.globenewswire.com/news-release/2022/05/31/2453170/0/en/MIMEDX-Receives-4-6-Million-Award-from-the-Department-of-Defense-to-Advance-the-Treatment-of-Combat-Casualty-Wounds-and-Burns.html,MDXG,0.3,Somewhat-Bullish,0.15244
"Leading Independent Proxy Advisory Firm ISS Recommends that MIMEDX Shareholders Vote ""FOR ALL"" of the Company's Proposals",20220525T212600,https://www.globenewswire.com/news-release/2022/05/25/2450813/0/en/Leading-Independent-Proxy-Advisory-Firm-ISS-Recommends-that-MIMEDX-Shareholders-Vote-FOR-ALL-of-the-Company-s-Proposals.html,MDXG,0.206774,Neutral,0.112086
"Leading Independent Proxy Advisory Firm Glass Lewis Recommends that MIMEDX Shareholders Vote ""FOR ALL"" of the Company's Proposals",20220520T130000,https://www.benzinga.com/pressreleases/22/05/g27321346/leading-independent-proxy-advisory-firm-glass-lewis-recommends-that-mimedx-shareholders-vote-for-a,MDXG,0.275331,Somewhat-Bullish,0.262429
MIMEDX Investor Presentation Highlights Clear Strategy for Value Creation,20220518T201800,https://www.globenewswire.com/news-release/2022/05/18/2446426/0/en/MIMEDX-Investor-Presentation-Highlights-Clear-Strategy-for-Value-Creation.html,MDXG,0.30145,Bullish,0.363672
Prescience Point Capital Management Calls on MiMedx to Confirm the Company Has Received Letters of Serious Concern from other Shareholders,20220518T125500,https://www.benzinga.com/pressreleases/22/05/n27274769/prescience-point-capital-management-calls-on-mimedx-to-confirm-the-company-has-received-letters-of,MDXG,0.384478,Bearish,-0.4197
CX: 5 Top-Rated Stocks Under $5 to Buy This Month,20220513T183903,https://stocknews.com/news/cx-sckt-btg-hnnm-mdxg-5-top-rated-stocks-under-5-to-buy-this-month/,MDXG,0.119068,Neutral,0.109318
MiMedx Group and Inozyme Stock See Action From Activist Investors,20220506T213000,https://www.barrons.com/articles/mimedx-group-and-inozyme-stock-see-action-from-activist-investors-51651872639,MDXG,0.682689,Neutral,0.003416
Prescience Point Capital Management Issues Open Letter to Shareholders of MiMedx Group,20220506T131200,https://www.prnewswire.com/news-releases/prescience-point-capital-management-issues-open-letter-to-shareholders-of-mimedx-group-301541456.html,MDXG,0.335631,Somewhat-Bearish,-0.313659
MIMEDX to Participate at Upcoming Investor Conferences,20220505T120000,https://www.globenewswire.com/news-release/2022/05/05/2436718/0/en/MIMEDX-to-Participate-at-Upcoming-Investor-Conferences.html,MDXG,0.479609,Neutral,0.104617
MiMedx: Q1 Earnings Snapshot,20220503T212307,https://apnews.com/article/business-georgia-earnings-marietta-4003d5b71d2361e2de63355529cd4f83,MDXG,0.98206,Somewhat-Bearish,-0.237921
MIMEDX Announces First Quarter 2022 Operating and Financial Results,20220503T203200,https://www.globenewswire.com/news-release/2022/05/03/2435104/0/en/MIMEDX-Announces-First-Quarter-2022-Operating-and-Financial-Results.html,MDXG,0.162339,Somewhat-Bullish,0.159554
MIMEDX Comments on Prescience Point's Recent Filing,20220429T130947,https://www.benzinga.com/pressreleases/22/04/g26896418/mimedx-comments-on-prescience-points-recent-filing,MDXG,0.275867,Somewhat-Bullish,0.192336
MIMEDX Comments on Prescience Point's Recent Filing,20220429T130900,https://www.globenewswire.com/news-release/2022/04/29/2432656/0/en/MIMEDX-Comments-on-Prescience-Point-s-Recent-Filing.html,MDXG,0.242296,Somewhat-Bullish,0.180136
"The Tendonitis Market to Exhibit Growth at a CAGR of 2.9% In The 7MM During The Study Period  ( 2018-30 ) , Assesses DelveInsight",20220414T153100,https://www.prnewswire.com/news-releases/the-tendonitis-market-to-exhibit-growth-at-a-cagr-of-2-9-in-the-7mm-during-the-study-period-2018-30-assesses-delveinsight-301525986.html,MDXG,0.118987,Neutral,-0.034119
Smith+Nephew announces new study showing GRAFIXâ„¢ Membrane cut the rate of diabetic foot ulcer recurrence in half compared to leading competitors,20220331T120000,https://www.prnewswire.com/news-releases/smithnephew-announces-new-study-showing-grafix-membrane-cut-the-rate-of-diabetic-foot-ulcer-recurrence-in-half-compared-to-leading-competitors-301514618.html,MDXG,0.050754,Neutral,0.010453
MiNK Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results,20220318T123000,https://www.globenewswire.com/news-release/2022/03/18/2406000/0/en/MiNK-Therapeutics-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results.html,MDXG,0.043898,Somewhat-Bullish,0.200587
MIMEDX to Present at the Canaccord Genuity Musculoskeletal Conference,20220315T120000,https://www.globenewswire.com/news-release/2022/03/15/2403336/0/en/MIMEDX-to-Present-at-the-Canaccord-Genuity-Musculoskeletal-Conference.html,MDXG,0.510338,Neutral,0.089259
